Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia

被引：0

作者：

Vinod Pullarkat ^{[1
]}

Keith W. Pratz ^{[2
]}

Hartmut Döhner ^{[3
]}

Christian Recher ^{[4
]}

Michael J. Thirman ^{[5
]}

Courtney D. DiNardo ^{[6
]}

Pierre Fenaux ^{[7
]}

Andre C. Schuh ^{[8
]}

Andrew H. Wei ^{[9
]}

Arnaud Pigneux ^{[10
]}

Jun-Ho Jang ^{[11
]}

Gunnar Juliusson ^{[12
]}

Yasushi Miyazaki ^{[13
]}

Dominik Selleslag ^{[14
]}

Martha L. Arellano ^{[15
]}

Chenglong Liu ^{[16
]}

Jean A. Ridgeway ^{[16
]}

Jalaja Potluri ^{[16
]}

Jovita Schuler ^{[16
]}

Marina Konopleva ^{[6
]}

机构：

[1] City of Hope Comprehensive Cancer Center,Department of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research

[2] University of Pennsylvania,Abramson Cancer Center

[3] Ulm University Hospital,Department of Internal Medicine III

[4] Centre Hospitalier Universitaire de Toulouse,Section of Hematology/Oncology, Department of Medicine

[5] The University of Chicago Medicine,Department of Medical Oncology and Hematology

[6] Montefiore-Einstein Comprehensive Cancer Center,Peter MacCallum Cancer Centre, Royal Melbourne Hospital

[7] Hôpital St. Louis/Assistance Publique-Hôpitaux de Paris and Université de Paris,Department of Hematology

[8] Princess Margaret Cancer Centre,Department of Hematology

[9] Walter and Eliza Hall Institute of Medical Research and University of Melbourne,Oncology, Samsung Medical Center

[10] CHU de Bordeaux,Department of Hematology

[11] Sungkyunkwan University School of Medicine,Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute

[12] Skåne University Hospital,Department of Hematology and Medical Oncology, Winship Cancer Institute

[13] Nagasaki University,undefined

[14] Algemeen Ziekenhuis Sint-Jan,undefined

[15] Emory University School of Medicine,undefined

[16] AbbVie Inc.,undefined

来源：

Blood Cancer Journal | / 15卷 / 1期

关键词：

D O I：

10.1038/s41408-025-01263-3

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] PHF6 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia
Bataller, Alex
Chien, Kelly S.
Sasaki, Koji
Montalban-Bravo, Guillermo
Kanagal-Shamanna, Rashmi
Urrutia, Samuel
Almanza-Huante, Emmanuel
Gener-Ricos, Georgina
Ravandi, Farhad
Jabbour, Elias
Kadia, Tapan
Borthakur, Gautam
Garcia-Manero, Guillermo
LEUKEMIA RESEARCH, 2023, 127
[22] TREATMENT OF THERAPY-RELATED ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASTIC SYNDROMES
BALLEN, KK
ANTIN, JH
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1993, 7 (02) : 477 - 493
[23] Therapy-Related Trilineage Mixed Phenotype Acute Leukemia Treated with Venetoclax and Azacitidine
Yamamoto, Jotaro
Yamaguchi, Kyosuke
Watanabe, Otoya
Kageyama, Kosei
Taya, Yuki
Kaji, Daisuke
Nishida, Aya
Uruga, Hironori
Takagi, Shinsuke
Ishiwata, Kazuya
Yamamoto, Hisashi
Masuda, Akiko
Takazawa, Yutaka
Yamamoto, Go
Mori, Yuki
Uchida, Naoyuki
Wake, Atsushi
INTERNAL MEDICINE, 2025,
[24] Predictive Model for Infection Risk in Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Patients Treated With Azacitidine; Azacitidine Infection Risk Model: The Polish Adult Leukemia Group Study
Madry, Krzysztof
Lis, Karol
Biecek, Przemyslaw
Mlynarczyk, Magda
Rytel, Agoda
Gorka, Michal
KacFrzyk, Piotr
Dutka, Magdalena
Rodzaj, Marek
Bolkun, Lukasz
Krochmalczyk, Dorota
Latka, Ewa
Drozd-Sokolowska, Joanna
Waszczuk-Gajda, Anna
Knopinska-Posluszny, Wanda
Kopinska, Anna
Subocz, Edyta
Masternak, Anna
Guzicka-Kazimierczak, Renata
Gil, Lidia
Machowicz, Rafal
Bilinski, Jaroslaw
Giebe, Sebastian
Czerw, Tomasz
Dwilewicz-Trojaczek, Jadwiga
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (05): : 264 - +
[25] Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
Leiming Xia
Wanlu Tian
Yiming Zhao
Lingling Jiang
Wei Qian
Lei Jiang
Ling Ge
Jianjun Li
Fengbo Jin
Mingzhen Yang
Signal Transduction and Targeted Therapy, 8
[26] Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia
Winters, Amanda C.
Gutman, Jonathan A.
Purev, Enkhtsetseg
Nakic, Molly
Tobin, Jennifer
Chase, Stephanie
Kaiser, Jeff
Lyle, Lindsey
Boggs, Chelsey
Halsema, Keri
Schowinsky, Jeffrey T.
Rosser, Julie
Ewalt, Mark D.
Siegele, Bradford
Rana, Vishal
Schuster, Steven
Abbott, Diana
Stevens, Brett M.
Jordan, Craig T.
Smith, Clayton
Pollyea, Daniel A.
BLOOD ADVANCES, 2019, 3 (20) : 2911 - 2919
[27] Azacytidine and Vorinostat in Patients with Chronic Lymphocytic Leukemia (CLL) Diagnosed with Therapy-Related Myelodysplastic Syndromes/Acute Myeloid Leukemia (t-MDS/AML)
Alvarado, Yesid
Keating, Michael J.
O'Brien, Susan
Kantarjian, Hagop M.
Wierda, William G.
Sneed, Troy
Jain, Nitin
Garcia-Manero, Guillermo
BLOOD, 2014, 124 (21)
[28] Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
Xia, Leiming
Tian, Wanlu
Zhao, Yiming
Jiang, Lingling
Qian, Wei
Jiang, Lei
Ge, Ling
Li, Jianjun
Jin, Fengbo
Yang, Mingzhen
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
[29] IMPACT OF AZACITIDINE TREATMENT ON INFECTIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA, MYELODYSPLASTIC SYNDROMES AND MYELODYSPLASTIC/MYELOPROLIFERATIVE SYNDROMES
Villegas, C.
Ortiz, S.
Javier, K.
Costa, S.
Ivars, D.
Collado, R.
Lopez, M.
Irene, L.
Roig, M.
Sanchez, M.
Perez, P.
Orero, M.
HAEMATOLOGICA, 2016, 101 : 483 - 483
[30] Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes
Voso, MT
Scardocci, A
Guidi, F
Zini, G
Di Mario, A
Pagano, L
Hohaus, S
Leone, G
BLOOD, 2004, 103 (02) : 698 - 700

← 1 2 3 4 5 →